Abacus Health Products (CSE: ABCS) (OTCQX: ABAHF) is the first company to develop a a family of OTC products blended with CBD hemp extract (Cannabis sativa L.) and began distribution to healthcare practitioners in 2016 under the CBD CLINIC brand name. CBD CLINIC products quickly became the #1 preferred external analgesics for thousands of practitioners […]

NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) a health and wellness CBD company, today announced that it has entered into a Retail Implementation Agreement dated August 30, 2019 (the “Agreement”) with New Implementation Program, LLC. Pursuant to the terms of the Agreement, NIP will provide to the Company distribution services and sale of […]

BevCanna Enterprises Inc. (CSE: BEV) announced that it has been awarded an Industrial Hemp Cultivation License from Health Canada, pursuant to the Cannabis Act (Canada) (the “Hemp License”). This highly-coveted license is a significant step in BevCanna’s plan to launch a portfolio of CBD-infused beverages and other consumable products. BevCanna also anticipates the issuance of […]

AREV Brands International Ltd. (CSE: AREV) (OTC: AREVF), is pleased to announce that it has contributed DNA samples from select BC Bud Depot genovarsTM to the inaugural batch run on the world’s first BeadArray genotype chip to be designed specifically for the cannabis genome. The Illumina Infinium HTS microarray, designed and wholly owned by C […]

AREV Brands International Ltd. (CSE: AREV) is pleased to announce that it has modified its sub critical “FFE” Fast Freeze Extraction systems to be fully scaleable to handle tonnes of biomass on a continuous bases and has developed a patentable method that increases the ability to separate waxes from biomass on the fly. AREV Brands […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the establishment of a Center of Excellence at Dr. Christine Vogel’s laboratory at New York University’s Center for Genomics and Systems Biology. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based […]

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]

Biome Grow Inc. (OTCQB: BIOIF) (CSE: BIO) announced that Mr. George Smitherman has joined Biome Grow’s executive management as Senior Vice President of Corporate Affairs. In this role, George will be leveraging his experience and knowledge in the Canadian health care sector to accelerate Biome’s growth in new operating verticals. His portfolio of responsibilities will […]

Based in Houston, Texas, SpinalCyte, LLC, is a regenerative medicine company developing an innovative solution for spinal replacement using human dermal fibroblasts. Currently, SpinalCyte holds 39 U.S. and international issued patents and has filed for an additional 100+ patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure […]

Pressure BioSciences, Inc. (OTCQB: PBIO) a leader in the development and sale of pressure-based instruments and platform technologies to the life sciences and other industries worldwide, today announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, a world-renown German research organization. Pressure BioSciences, Inc. is pressure-based platform solutions for the […]